Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLE vs MRNA✓SelectedUSD · MRNAXLE vs MRNA performance historyLatest closeAs of-1.96%11/16
Stock and ETF performance explorer

XLE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+68.8%
MRNA return
+182.7%
Excess return
-113.9%
Maximum drawdown
-20.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.0%-3.6%+1.7%-1.9%
7D+2.8%-20.0%+22.8%+2.9%
30D-6.7%-1.3%-5.4%-6.7%
3M+3.5%+240.0%-236.5%+2.2%
6M+8.6%+339.0%-330.4%+5.8%
YTD+45.3%+630.0%-584.7%+36.8%
1Y+42.4%+769.1%-726.7%+32.5%
3Y+68.8%+181.2%-112.4%+52.7%
All+68.8%+182.7%-113.9%+52.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling